Congress quietly expands postpartum care for millions of Medicaid women

What it does

This bill directs the Secretary of Health and Human Services to issue guidance to states on how to cover pelvic health services (pelvic floor exams and physical therapy) for women during pregnancy and the postpartum period under Medicaid and CHIP. It also requires a Government Accountability Office study on coverage gaps and authorizes $2 million per year for a CDC-led public education campaign to train health professionals and inform postpartum women about these services.

Why we flagged it

The bill's operative mechanism is federal guidance and education to increase Medicaid/CHIP coverage of postpartum pelvic health services. It is a straightforward public-health measure with no hidden riders, tax carve-outs, or private immunity grants.

What the text implies

• Guidance may incentivize states to expand Medicaid coverage of pelvic health services, potentially increasing state Medicaid spending if federal matching funds are not increased proportionally.
• The definition of 'postpartum period' as the longer of lactation or 6 months may create administrative complexity for states determining eligibility windows and coverage duration.
• Public education campaign may increase demand for pelvic health physical therapy, creating workforce shortages if training and supply of pelvic health physical therapists do not scale accordingly.
• The bill does not mandate coverage—it directs guidance and study—so actual coverage expansion depends on state adoption and appropriations, creating implementation uncertainty.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill expands access to postpartum pelvic health care—a medically underserved area affecting millions of women—by directing federal guidance to states and funding public education. It does not restrict citizens' rights or remedies, impose new costs on individuals, or create private carve-outs; instead, it increases transparency and access to evidence-based care during a critical health window.

Who stands to gain

• pelvic health physical therapists and clinics
• healthcare providers offering pelvic floor examinations
• medical device and pharmaceutical companies serving pelvic health (potential indirect benefit from e

Named in the bill

Department of Health and Human Services, Centers for Disease Control and Prevention, Health Resources and Services Administration, Medicaid (Title XIX, Social Security Act), Children's Health Insurance Program (CHIP, Title XXI), Government Accountability Office, State health agencies

Where it stands

2 cosponsors: 1 Democrats, 1 Republicans.

• May 11, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• May 11, 2026 — Referred to Senate Committee on Finance · Congress.gov: “Read twice and referred to the Committee on Finance”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $119,592 in lobbying spend. A filing names 18 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Lisa Blunt Rochester, the sponsor, reported $317,500 in PAC receipts in the 2026 cycle.

• Zero to Three: National Center for Infants, Toddlers, and Families — $119,592 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.